Federal Register / Vol. 78, No. 42 / Monday, March 4, 2013 / Notices 14103 

Engagement/Mailstop 0440; Department 

of Homeland Security; 245 Murray Lane 

SW.; Washington, DC 20528–0440, 

email: 

AcademicEngagement@hq.dhs.gov, tel: 

202–447–4686 and fax: 202–447–3713. 

SUPPLEMENTARY INFORMATION: Notice of 

this meeting is given under the Federal 

Advisory Committee Act, 5 U.S.C. App. 

(Pub. L. 92–463). The HSAAC provides 

advice and recommendations to the 

Secretary and senior leadership on 

matters relating to student and recent 

graduate recruitment; international 

students; academic research; campus 

and community resiliency, security and 

preparedness; and faculty exchanges. 

Agenda: The five HSAAC 

subcommittees (Student and Recent 

Graduate Recruitment, Homeland 

Security Academic Programs, Academic 

Research and Faculty Exchange, 

International Students, and Campus 

Resilience) will give progress reports 

and may present draft recommendations 

for action in response to initial taskings 

issued by Secretary Napolitano at the 

March 20, 2012 full committee meeting, 

including: How to attract student 

interns, student veterans, and recent 

graduates to jobs at DHS; how to use 

social media and other means of 

communication to most effectively 

reach this audience; how to ensure that 

students and recent graduates of 

Historically Black Colleges and 

Universities, Hispanic Serving 

Institutions, Tribal Colleges and 

Universities, and other Minority Serving 

Institutions know of and take advantage 

of DHS internship and job 

opportunities; how to define the core 

elements of a homeland security degree 

at the Associates, Bachelors and Masters 

levels; how to apply the Transportation 

Security Administration (TSA) 

Associates Program model to other 

segments of the DHS workforce who 

wish to pursue a community college 

pathway; how to form relationships 

with 4-year schools so that DHS 

employees’ credits transfer towards a 

higher level degree; how to enhance 

existing relationships between the 

Federal Emergency Management 

Agency’s (FEMA) Emergency 

Management Institute and the higher 

education community to support 

Presidential Policy Directive 8 (PPD–8), 

expand national capability, and support 

a whole community approach; how to 

expand DHS cooperation with the 

Department of Defense academies and 

schools to provide current DHS 

employees with educational 

opportunities; how academic research 

can address DHS’ biggest challenges; 

how DHS operational Components can 

form lasting relationships with 

universities to incorporate scientific 

findings and Research and Development 

into DHS operations and thought 

processes; how universities can 

effectively communicate to DHS 

emerging scientific findings and 

technologies that will make DHS 

operations more effective and efficient; 

how to create a robust staff/faculty 

exchange program between academe 

and DHS; how DHS can improve its 

international student processes and 

outreach efforts; how DHS can better 

communicate its regulatory, policies 

and procedures to the academic 

community; how DHS can 

accommodate and support emerging 

trends in international education; how 

colleges and universities use specific 

capabilities, tools, and processes to 

enhance campus and community 

resilience as well as the cyber and 

physical infrastructure; how DHS grant 

programs may be adjusted to support 

resiliency-related planning and 

improvements; how campuses can 

better integrate with community 

planning and response entities; how to 

implement the whole community 

approach and preparedness culture 

within student and neighboring 

communities; how to strengthen ties 

between the DHS Federal Law 

Enforcement Training Center and 

campus law enforcement professionals; 

and how DHS can better coordinate 

with individual campus IT departments 

on the risks towards and attacks on 

computer systems and networks. The 

meeting materials will be posted to the 

HSAAC Web site at: http:// 

www.dhs.gov/homeland-securityacademic-advisory-council-hsaac no 

later than March 15, 2013. 

Responsible DHS Official: Lauren 

Kielsmeier, 

AcademicEngagement@hq.dhs.gov, 

202–447–4686. 

Dated: February 26, 2013. 

Lauren Kielsmeier, 

Executive Director for Academic Engagement. 

[FR Doc. 2013–04861 Filed 3–1–13; 8:45 am] 

BILLING CODE 9110–9B–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2013–0018] 

Request for Information (RFI) 

Regarding the Planned Biotechnology 

Development Module (BDM) as Part of 

the National Bio and Agro-Defense 

Facility (NBAF) and Notice of Public 

Workshop 

AGENCY: Department of Homeland 

Security, Science and Technology 

Directorate. 

ACTION: Request for Information and 

Notice of Workshop. 

SUMMARY: The Department of Homeland 

Security (DHS) Science and Technology 

Directorate (S&T), Office of National 

Laboratories (ONL) and the United 

States Department of Agriculture 

(USDA), Agricultural Research Service 

(ARS) and Animal and Plant Health 

Inspection Service (APHIS) are 

requesting information regarding 

utilization alternatives for the planned 

Biotechnology Development Module 

(BDM) a planned component of the 

National Bio and Agro-Defense Facility 

(NBAF). The BDM will provide a 

distinct environment for scientific 

synergy, attract animal health industry 

involvement and serve to encourage 

public-private partnerships as 

countermeasures developed for 

agricultural biodefense emerge from 

NBAF. The information provided by 

industry and other interested 

stakeholders in response to this RFI will 

be used by DHS and USDA to better 

plan the scope, capacity, and utilization 

alternatives for the BDM facility. DHS 

and USDA are requesting that this 

information be provided in writing per 

the guidelines below. There will also be 

an opportunity for interested parties to 

participate in a workshop with DHS and 

USDA. 

DATES: The Request for Information 

period will be 60 days (March 5 to May 

3, 2013). Please submit written 

information no later than May 3, 2013. 

The workshop will be held on March 

22, 2013 from 8:30 a.m.–4:00 p.m. CST. 

ADDRESSES: Written Information should 

be submitted via email to: 

nbafprogrammanager@dhs.gov ATTN: 

Mary Goobic. 

The workshop will be held at the 

Kansas State University Olathe Campus 

(Forum Hall), 22201 W. Innovation 

Drive, Olathe, KS 66061. 

If you are interested in participating 

in the public workshop, please register 

at www.dhs.gov/nbaf by March 18, 2013. 

FOR FURTHER INFORMATION CONTACT: 

Mary Goobic, 202–254–6144. 


sroberts on DSK5SPTVN1PROD with NOTICES
14104 Federal Register / Vol. 78, No. 42 / Monday, March 4, 2013 / Notices 

SUPPLEMENTARY INFORMATION: 

Request for Information Instructions 

Written information should be 

submitted via email to: 

nbafprogrammanager@dhs.gov, subject 

line should read: ‘BDM RFI Response, 

ATTN: Mary Goobic’ no later than May 

2, 2013. Submissions should be limited 

to 5 pages and should address the 

following four main topics: 

• Scope of the BDM (requirements, 

program drivers, technology). 

• Operational Requirements (staffing, 

regulatory, equipment needs). 

• Utilization Alternatives 

(collaboration space, user facility, work 

for others, etc). 

• Mechanisms to Facilitate 

Collaboration Between Industry and 

Government (joint venture). 

The written information should 

provide feedback on the above 

information and address the following 

questions (please see below for 

additional details on the plans for the 

BDM): 

1. Are there additional or different 

perceived needs for the BDM? 

2. How much interest is there for 

utilizing the BDM? 

3. Is the BDM right sized for capacity? 

4. What are the proposed utilization 

alternatives for the BDM? 

5. What are the possible mechanisms 

to enhance collaboration between the 

BDM and the animal health biologics 

industry? 

6. Provide lessons learned for DHS to 

consider regarding the BDM. 

Workshop 

To further facilitate the information 

exchange between the government and 

the biologics industry, DHS will 

conduct a public workshop as part of 

the RFI process. The goals of the 

workshop are: (1) Provide an overview 

of the planned mission requirements of 

the BDM; (2) Provide the proposed BDM 

design; (3) Review analogous current 

and planned biological countermeasure 

development initiatives; (4) Gauge 

industry interest in the utilization of the 

BDM to enhance collaboration. This 

workshop is designed to provide 

information on the NBAF BDM and how 

it fits within the broader context of 

countermeasure development for 

protecting U.S. agriculture. A panel 

discussion is scheduled to give industry 

an opportunity to share lessons learned 

and insights on BDM related operations. 

The workshop will be held from 8:30 

a.m.–4:00 p.m. CST on March 22, 2013 

in Olathe, KS at the Kansas State 

University Olathe campus. If you are 

interested in attending, please register at 

the following link: www.dhs.gov/nbaf by 

March 18, 2013. This workshop will 

include several panel discussions and 

we encourage participation from 

industry representatives to present their 

perspectives and lessons learned on this 

opportunity for collaboration with the 

federal government. If you are interested 

in participating in the panel 

discussions, please indicate a 

representative from your organization to 

serve as a panel member when you 

register online. Early registration is 

recommended due to limited seating. 

There is no registration fee for the 

workshop. If you need special 

accommodations due to a disability, 

please contact Mary Goobic at 202–254– 

6144 at least 7 days in advance of the 

workshop. 

Additional information such as design 

layouts, schematics, any other 

significant questions and any 

amendments or changes to the RFI will 

be posted on the NBAF Web site 

(www.dhs.gov/nbaf). Questions 

regarding the workshop may be 

submitted by email to 

nbafprogrammanager@dhs.gov ATTN: 

Mary Goobic. 

Scope of the BDM 

The BDM is designed to support the 

early development and eventual license 

of products/reagents discovered at the 

NBAF laboratory. The goal of the BDM 

is to provide product quality assurance, 

master cell and seed stocks, upscale 

validation, and assay development to 

support the development of biologics, 

which will allow quicker regulatory 

reviews and approvals of materials and 

products to respond to potential 

emergencies and threats to national and 

global food stocks. The BDM would 

address critical needs, including pilot 

manufacturing processes to effectively 

transfer new technologies to the 

veterinary biologics and 

biopharmaceutical industries and, in 

some emergency situations, to the end 

users in the field to control and 

eradicate a foreign animal disease 

outbreak. 

One of the limitations of moving 

animal health research results to 

agribusiness is the cost and 

inefficiencies in developing the 

manufacturing process; this is an even 

a bigger issue for foreign animal 

diseases since there is a limited market 

for countermeasures developed to 

control diseases that do not exist in the 

United States. The BDM will enable the 

federal government (USDA–ARS, 

USDA–APHIS, and DHS) to implement 

early product development initiatives in 

partnership with private sector greatly 

increase the rate of success of 

technology transfers. The BDM will be 

constructed to enable Good 

Manufacturing Practices (GMP) and 

support translational studies by 

producing test materials to develop 

potential therapeutic and preventive 

countermeasures for animal agriculture. 

The BDM will support customers from 

all three NBAF user groups (DHS S&T, 

ARS, and APHIS) as well as potential 

industry collaborators. The proposed 

BDM is intended to produce small scale 

GMP-compliant biological 

countermeasures for supporting efficacy 

studies and early phase clinical trials in 

response to DHS and USDA program 

requests. The BDM has been designed to 

manufacture experimental diagnostics, 

biologics, and therapeutics designed for 

the detection, control, and eradication 

of foreign animal diseases in the United 

States. These countermeasures may also 

be used to help developing countries 

control and where feasible eradicate 

endemic agents that pose a threat to 

United States animal agriculture. The 

model for the GMP/BDM facility, and its 

supporting areas, is to create small 

quantities of materials beyond proof of 

concept, using clinical processing to 

provide consistent/reproducible 

products and processes to confirm 

product safety and effectiveness. The 

design of the GMP/BDM Suite will 

support clinical investigations focusing 

on product safety, purity, potency, and 

efficacy that will lead to licensed 

products in compliance with U.S. 

regulations as well as international 

standards. The BDM’s design will 

provide flexibility for a variety of 

product types and manufacturing 

processes, including production of 

monoclonal antibodies, recombinant 

proteins for therapeutics/diagnostic 

applications, and live or inactivated 

recombinant viral and bacterial 

vaccines, and dedicated areas for 

formulations and aseptic fill-finish 

operations. The development of 

qualified master cell and seed stocks 

(for manufacturing viral and bacterial 

vaccines) will be a critical activity to 

accomplish the mission. In addition, the 

facility will support the evolution of 

existing countermeasures (vaccine and 

diagnostic) programs by providing small 

scale production of experimental test 

materials for use in the clinical and 

analytical components of late stage 

discovery and early stage development 

of countermeasures discovered by 

NBAF scientists. 

Operational Requirements 

The BDM is designed as part of the 

NBAF laboratory to support the growth, 

collection, and purification of products 

in individual Production and Diagnostic 

Reagent Production Suites. The BDM is 


sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 42 / Monday, March 4, 2013 / Notices 14105 

8,300 square feet and consists of 

production suites and general support 

spaces for small scale production of 

biological countermeasure materials for 

supporting efficacy studies and early 

phase clinical trials. By implementing 

validated processes to reproduce 

materials consistently, the program will 

hasten candidate technology transfer 

and countermeasure product candidate 

transition from NBAF to industry 

partners for scale-up and commercial 

manufacturing. This will also allow for 

more targeted outsourcing of 

countermeasures development 

processes, as candidates emerging from 

the NBAF will be more attractive to the 

animal biologics industry. 

The BDM will meet the APHIS Center 

for Veterinary Biologics requirements 

for manufacturing biological products 

and will have the flexibility, when 

necessary, to operate in accordance with 

current GMP regulations as described in 

Title 21 CFR Parts 210, and 211, such 

as during the production of master 

seeds, drug substances (DS), and drug 

products (DP). The NBAF BDM will 

allow the production of pilot lots of 

veterinary biological candidates to be 

tested to assess their potential for 

successful licensure by the APHIS 

Center of Veterinary Biologics, and will 

be produced under APHIS 

manufacturing requirements. APHIS has 

issued a comprehensive set of 

regulations governing the licensing of 

viruses, serums, toxins, or analogous 

products (9 CFR Parts 101–123). These 

regulations broadly categorize viruses, 

serums, toxins or analogous products as 

‘‘biological products’’ at any stage of 

production intended for use in the 

treatment of animals and act primarily 

through the direct stimulation, 

supplementation, enhancement, or 

modulation of the immune system or 

immune response. Additional veterinary 

drugs or products will be submitted to 

and licensed by the FDA Center for 

Veterinary Medicine. Candidates will be 

manufactured in compliance with the 

appropriate CFR requirements for the 

conduct of controlled and uncontrolled 

studies utilizing active components in 

animal models. 

The BDM will operate to enable 

positive and negative air flows, as well 

as BSL–2 containment with BSL–3 

enhanced production areas to support 

the development of inactivated and 

attenuated recombinant viral products. 

The BDM will be utilized 24 hours a 

day, based on a year-round production 

schedule once fully operational. The 

facility will also allow simultaneous 

production of small amounts of multiple 

vaccine candidates. The BDM is 

attached to the NBAF laboratory to 

assure proximity. Card/Access Security 

Control will be established to maintain 

access control to the building as well as 

each of the manufacturing suites and 

access corridors of the GMP/BDM. 

Proximity Card access will be 

established to assure that only properly 

trained and security authorized 

personnel are allowed in each of the 

zoned areas of the module. Card access 

will also be used to maintain the clean 

zones and material and equipment 

transfer into the manufacturing suites. 

Air cleanliness classifications are 

established in the GMP/BDM per ISO 

and International EU requirements for 

possible DS and DP exposure. Open 

product manufacturing, processing, and 

fill-finish will be performed under 

laminar flow classified room air or 

within containment via biosafety 

cabinets (BSC) or laminar flow (LAF) 

hoods to assure product integrity. Air 

cleanliness will be maintained within 

the product exposure areas under Class 

100/A, ISO 5 conditions. Cleanliness of 

this air will be maintained through 

cascade of classifications in adjacent 

areas required to maintain flow of 

material, equipment, and personnel 

through the space. These classifications 

will be maintained for cleanliness 

requirements and containment 

requirements of the CDC, and the FDA 

for materials in use and products 

manufactured or finished. 

Pressurization of spaces to supplement 

air flows will also be utilized to assure 

containment of particulates, 

contaminants, and regulated agents. 

Utilization Alternatives 

DHS plans to operate the BDM as a 

government owned, government 

operated (GOGO) laboratory. However, 

DHS is evaluating utilization 

alternatives for the BDM that will 

maximize the use of the facility. DHS is 

seeking feedback from industry on 

utilization alternatives or alternative 

approaches such as privatizing the 

construction and operations of the BDM. 

The key criteria that DHS is 

considering in its evaluation are: 

• Facility and Scientific Oversight. 

• Ability to Respond to Changing 

Mission. 

• Facility Availability. 

• Ability to Establish Collaborations. 

• Safety and Security. 

• Technology Transfer. 

• Cost Effectiveness. 

• Outside Funding. 

• Risk of Failure/Bankruptcy. 

• Liability. 

DHS would like feedback on other 

criteria that should be considered in the 

decision making process. 

Mechanisms To Facilitate Collaboration 

With Industry 

The BDM presents opportunities to 

further collaborate with industry 

partners in the development of 

countermeasures to protect animal 

agriculture in the United States, as well 

as developing countries that are 

endemic for priority diseases that pose 

a threat to global food security. The 

BDM will enable and facilitate 

technology transfer to national and 

multinational industry partners and 

contract manufacturing organizations 

(CMO) for scale-up and quicker turnover 

to commercial product manufacturing. 

The importance of on-site potential for 

development and scale-up production of 

material has been recognized by DHS 

and USDA as an important capability 

for the site as an integral step towards 

the development of countermeasures. 

Additional feedback or suggestions on 

other potential opportunities for 

collaboration are welcome. 

NBAF Mission 

The United States’ food and animal 

agriculture supply is a highly integrated, 

open, global, and complex 

infrastructure. Increased imports of 

agricultural products, climate change, 

and growing numbers of international 

travelers to and from the U.S. have 

opened our food supply to possible 

intentional, natural, or accidental 

foreign animal disease outbreaks. The 

recent pandemic H1N1 outbreak and 

other regional foot-and-mouth disease 

outbreaks have demonstrated the 

vulnerabilities present when there is a 

lack of available countermeasures, and 

other rapid response capabilities to curb 

outbreak disease. The food and 

agriculture industries are a significant 

contributor to U.S. economic prosperity; 

therefore, the loss of a significant food 

market would have dire economic and 

potentially human health consequences. 

To supply the needed capabilities, the 

DHS and the USDA have the joint 

responsibility to protect our Nation’s 

animal agriculture and public health 

from these threats. The DHS is leading 

these efforts through the construction of 

the NBAF in Manhattan, Kansas. 

NBAF will be a state-of-the-art 

biocontainment facility for the study of 

foreign animal, emerging and zoonotic 

(transmitted from animals to humans) 

diseases that threaten the U.S. animal 

agriculture and public health. NBAF 

will provide and strengthen our nation 

with critical capabilities to conduct 

research, develop vaccines and other 

countermeasures, and train 

veterinarians in preparedness and 

response against these diseases. For the 


sroberts on DSK5SPTVN1PROD with NOTICES
14106 Federal Register / Vol. 78, No. 42 / Monday, March 4, 2013 / Notices 

past 50 years, the Plum Island Animal 

Disease Center (PIADC) has served our 

nation as the primary facility to conduct 

research on livestock diseases. However, 

PIADC is nearing the end of its life-cycle 

and needs to be replaced in order to 

meet U.S. research requirements and 

ensure the timely development of 

countermeasures in the event of an 

outbreak. NBAF meets that need and 

will serve as a replacement for the 

PIADC facility. Strategically, NBAF will 

boast of new and expanded capabilities, 

specifically, Biosafety Level (BSL) 4 

containment for the study of highconsequence diseases affecting livestock 

and people. Specifically, NBAF will 

meet its mission by (1) providing 

enhanced capabilities to research, 

rapidly detect, and provide training on 

foreign animal, emerging and zoonotic 

diseases in livestock; (2) providing 

expanded vaccine and countermeasure 

development capabilities; and (3) 

replacing and expanding research 

currently performed at the PIADC in 

Orient Point, New York while 

continuing the partnership between the 

DHS and the USDA–ARS and USDA– 

APHIS. 

NBAF will serve as a U.S. government 

facility capable of rapidly producing 

experimental biological, diagnostic, and 

vaccine related products for potential 

use by USDA in an outbreak of an 

emerging or foreign animal disease. 

Initially, the following diseases would 

be studied at NBAF and would also 

require BSL–3 and BSL–4 laboratory 

capabilities: Nipah Virus, Hendra Virus, 

African Swine Fever, Rift Valley Fever, 

Japanese Encephalitis Virus, Foot and 

Mouth Disease, Classical Swine Fever, 

and Contagious Bovine 

Pleuropneumonia. The pathogens 

studied at the NBAF may change based 

upon continued evaluation of risks to 

U.S. agricultural system. 

Dated: February 26, 2013. 

Daniel M. Gerstein, 

Deputy Under Secretary, Science and 

Technology Directorate, U.S. Department of 

Homeland Security. 

[FR Doc. 2013–04919 Filed 3–1–13; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5690–N–04] 

Notice of Proposed Information 

Collection for Public Comment 

Enterprise Income Verification (EIV) 

Systems—Debts Owed to Public 

Housing Agencies and Terminations 

AGENCY: Office of the Assistance 

Secretary for Public and Indian 

Housing, HUD. 

ACTION: Notice of proposed information 

collection. 

SUMMARY: The proposed information 

collection requirement described below 

will be submitted to the Office of 

Management and Budget (OMB) for 

review, as required by the Paperwork 

Reduction Act. The Department is 

soliciting public comments on the 

subject proposal. 

This information collection is 

required to identify families who no 

longer participate in a HUD rental 

assistance program due to adverse 

termination of tenancy and/or 

assistance, and owe a debt to a Public 

Housing Agency (PHA). The 

information is used by PHAs to 

determine a family’s suitability for 

rental assistance, and avoid providing 

limited Federal housing assistance to 

families who have previously 

demonstrated an inability to comply 

with HUD program requirements or who 

have an unpaid debt to a PHA. 

DATES: Comments Due Date: May 3, 

2013. 

ADDRESSES: Interested persons are 

invited to submit comments regarding 

this proposal. Comments should refer to 

the proposal by name and/or OMB 

Control number and sent to: Colette 

Pollard, Departmental Reports 

Management Officer, QDAM, 

Department of Housing and Urban 

Development, 451 7th Street SW., Room 

4178, Washington, DC 20410–5000; 

telephone 202.402.3400 (this is not a 

toll-free number) or email Ms. Pollard at 

Collette.Pollard@hud.gov for a copy of 

the proposed forms or other available 

information. 

FOR FURTHER INFORMATION CONTACT: 

Arlette Mussington, Office of Policy, 

Programs and Legislative Initiatives, 

Office of Public and Indian Housing, 

Department of Housing and Urban 

Development, 451 7th Street SW., 

L’Enfant Plaza, Room 2206, Washington, 

DC, telephone (202) 402–4109, for 

copies of other available documents 

(this is not a toll-free number.) 

SUPPLEMENTARY INFORMATION: The 

Department will submit the proposed 

information collection to the Office of 

Management and Budget (OMB) for 

review, as required by the Paper 

Reduction Act of 1995 (44 U.S.C. 

chapter 35, as amended). 

This Notice is soliciting comments 

from members of the public and affected 

agencies concerning the proposed 

collection of information to: (1) Evaluate 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information will have practical utility; 

(2) evaluate the accuracy of the agency’s 

estimate of the burden of the proposed 

collection of information; (3) enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

minimize the burden of the collection of 

information on those who are to 

respond, including through the use of 

appropriate automated collection 

techniques or other forms of information 

technology; e.g., permitting electronic 

submission of responses. 

This notice also lists the following 

information: 

Title of Proposal: Debts Owed to 

Public Housing Agencies & 

Terminations. 

OMB Control Number: 2577–0266. 

Description of the need for the 

information and proposed use: In 

accordance with 24 CFR 5.233, 

processing entities that administer the 

Public Housing, Section 8 Housing 

Choice Voucher, Moderate 

Rehabilitation programs are required to 

use HUD’s Enterprise Income 

Verification (EIV) system to verify 

employment and income information of 

program participants and to reduce 

administrative and subsidy payment 

errors. The EIV system is a system of 

records owned by HUD, as published in 

the Federal Register on July 20, 2005 at 

70 FR 41780 and updated on August 8, 

2006 at 71 FR 45066. 

The Department seeks to identify 

families who no longer participate in a 

HUD rental assistance program due to 

adverse termination of tenancy and/or 

assistance, and owe a debt to a Public 

Housing Agency (PHA). In accordance 

with 24 CFR 982.552 and 960.203, the 

PHA may deny admission to a program 

if the family is not suitable for tenancy 

for reasons such as, but not limited to: 

Unacceptable past performance in 

meeting financial obligations, history of 

criminal activity, eviction from 

Federally assisted housing in the last 

five years, family has committed fraud, 

bribery, or any other corrupt or criminal 

act in connection with a Federal 

housing program, or if a family 

currently owes rent or other amounts to 

the PHA or to another PHA in 


sroberts on DSK5SPTVN1PROD with NOTICES